Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Bestrophin Blocking Peptide (AC1256)
Cat.#: ACPP-1256
Specifications
Despition Bestrophin Blocking Peptide for Immunodepletion, Immunocompetition SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1335 Nicotinic Acetylcholine Receptor alpha 7 Blocking Peptide (AC1335) 250 µg inquiry ACPP-1374 Human Ephrin A4 Protein (AC1374) 2 µg inquiry ACPP-1760 Human Thyroid Stimulating Hormone Receptor (Active) Protein (AC1760) 100 µg inquiry ACPP-1132 Recombinant Human Calbindin Protein (AC1132) 25 µl inquiry ACPP-1681 Human CALN1 Protein (AC1681) 1 µg inquiry ACPP-1332 GAD65 Blocking Peptide (AC1332) 250 µg inquiry ACPP-1692 Human GLUL Protein (AC1692) 5 µg inquiry ACPP-1202 Pin1 Blocking Peptide (AC1202) 250 µg inquiry ACPP-1785 Human NEUROG3 Protein (AC1785) 2 µg inquiry ACPP-1126 Recombinant Human Peripherin Protein (AC1126) 25 µl inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket